Public health researcher at RTI International. Interests include math modeling of chronic conditions, community health, and HIV. All opinions are my own.
See our updated estimates for the impact for provision of both LA and daily oral #PrEP to reduce #HIV incidence. Very much appreciate the work of the HIV+HEP policy institute and collaborating with @RTI_Intl colleagues on this work. PrEP access matters!
New @HIVHep#modeling shows 87% more #HIV treatment costs averted by ↑long-acting #PrEP versus only daily oral PrEP, saving $4.25B over 10 years. Everyone who needs PrEP must be able to access the #Rx best suited to their needs. It saves $ and lives: https://t.co/B2wUc0vESZ
Friends don't let friends make bad charts!
Chenxin Li, pulled together a lot of great advice for data visualization, with clear "do this, not that" examples for each item.
Here are a few of my favorites, see the link below for more.
The American Heart Association will release a new clinical tool that removes race as a factor in predicting who will have heart attacks or strokes. https://t.co/2V04KlgQ85
New findings from @CDCPCD@ASTHO@NACCHOalerts:
Improving SDOH–Getting Further Faster | Using the Prevention Impacts Simulation Model to Estimate Long-Term Impacts of Multisector Community Partnerships’ Efforts to Address Social Determinants of Health https://t.co/sbdPAMNzWA
@RTI_Intl used PRISM to evaluate 27 #community health partnerships’ #SDOH interventions. Results show potential to prevent 880 deaths & save $125.7M in medical costs over 20 years.
@RTI_Intl co-authored research (@sneuwahl) finds that low-dose aspirin can be a low-cost, effective treatment to reduce preterm birth and perinatal death for women who have never given birth to a liveborn neonate. Read more in @LancetGH here: https://t.co/ieIlRQI1Fv
JAMA EIC @KBibbinsDomingo spoke with authors of a Viewpoint on a recent OPTN decision to modify kidney transplant wait times for Black individuals affected by eGFR calculations. In this excerpt, @EbonyBoulware speaks on the harms of race-based medicine. https://t.co/itwBf2D6hR
A hoped-for HIV vaccine developed by Johnson and Johnson was found to be ineffective in Phase 3 trials, prolonging decades-long frustration to beat an elusive foe. https://t.co/YNsOb08kcE
Pleased to share our manuscript analyzing patient times at COVID vax clinics. We hope these findings can help future planning of mass #vaccination clinics. Collecting these data and seeing clinics in action was a bright point of 2021. #PublicHealth https://t.co/hAZsPdUSFG
@HIVHep urges #Congress to fund a natl #PrEP program.- We estimate $521M needed in yr 1 ($6.2B over 10 yrs) to pay for PrEP meds & services as well as outreach & clinical capacity expansion. Read our press release & full report: https://t.co/TsScj7bWxM #worldaidsday2022
Was reminded today of this excellent list of scientific jargon to avoid, from R Somerville and @ClimateComms long ago but still completely relevant, especially as climate change work has become even more interdisciplinary.